Reduction of false positives using zone-specific prostate-specific antigen density for prostate MRI-based biopsy decision strategies.
Hamm CA, Baumgärtner GL, Padhani AR, Froböse KP, Dräger F, Beetz NL, Savic LJ, Posch H, Lenk J, Schallenberg S, Maxeiner A, Cash H, Günzel K, Hamm B, Asbach P, Penzkofer T.
Hamm CA, et al. Among authors: asbach p.
Eur Radiol. 2024 Mar 28. doi: 10.1007/s00330-024-10700-z. Online ahead of print.
Eur Radiol. 2024.
PMID: 38538841